Literature DB >> 21191292

Evaluation and management of glaucoma after keratoprosthesis.

Michael Banitt1.   

Abstract

PURPOSE OF REVIEW: To review the causes and treatment of glaucoma in Boston keratoprosthesis (K-pro) recipients. RECENT
FINDINGS: Glaucoma exists in up to three-quarters of patients who undergo K-pro surgery. After K-pro placement, intraocular pressure (IOP) is measured by digital palpation, which has been found to be reliable in trained observers. The onset or progression of glaucoma in K-pro patients should be monitored through visual field testing, direct visualization and structural imaging of the optic nerve. Although medical therapy is an option, one-half to three-quarters of K-pro recipients are surgically managed with a glaucoma drainage device (GDD) or, less commonly, cyclophotocoagulation.
SUMMARY: Glaucoma is a common and permanent blinding sequelae of K-pro surgery. In K-pro patients, elevated IOP and changes in the optic nerve head should result in a high index of suspicion for glaucoma. Management is frequently surgical and typically entails placement of a GDD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21191292     DOI: 10.1097/ICU.0b013e328343723d

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  13 in total

1.  Successful acute and late management of a chemical burn with primary implantation of Boston type 1 keratoprosthesis.

Authors:  Abhishek Ranjan; Sirisha Senthil; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2015-08-26

2.  Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases.

Authors:  Maria Fideliz de la Paz; Josef Stoiber; Valeria de Rezende Couto Nascimento; Juan Alvarez de Toledo; Orang Seyeddain; Wolfgang Hitzl; Günther Grabner; Rafael I Barraquer; Ralph Michael
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-25       Impact factor: 3.117

3.  Innovative approaches to glaucoma management of Boston keratoprosthesis type 1.

Authors:  Thasarat S Vajaranant; Jessica Liu; Jacob Wilensky; M Soledad Cortina; Ahmad A Aref
Journal:  Curr Ophthalmol Rep       Date:  2016-07-26

Review 4.  Glaucoma management after corneal transplantation surgeries.

Authors:  Helen L Kornmann; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

5.  Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.

Authors:  Mohsin H Ali; Mark S Dikopf; Anthony G Finder; Ahmad A Aref; Thasarat Vajaranant; Jose de la Cruz; Maria Soledad Cortina
Journal:  Cornea       Date:  2018-05       Impact factor: 2.651

6.  Glaucoma and corneal transplant procedures.

Authors:  Ammar M Al-Mahmood; Samar A Al-Swailem; Deepak P Edward
Journal:  J Ophthalmol       Date:  2012-01-18       Impact factor: 1.909

Review 7.  Keratoprostheses for corneal blindness: a review of contemporary devices.

Authors:  Venkata S Avadhanam; Helen E Smith; Christopher Liu
Journal:  Clin Ophthalmol       Date:  2015-04-16

8.  Visually evoked potentials in a patient with a fyodorov-zuev keratoprosthesis.

Authors:  Roy Schwartz; Adiel Barak; Hadas Newman
Journal:  Case Rep Ophthalmol       Date:  2015-01-14

9.  Intra-Ocular Pressure Measurement in a Patient with a Thin, Thick or Abnormal Cornea.

Authors:  Colin I Clement; Douglas G A Parker; Ivan Goldberg
Journal:  Open Ophthalmol J       Date:  2016-02-29

10.  Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.

Authors:  Mark Lin; Anand Bhatt; Asghar Haider; Grace Kim; Marjan Farid; Mason Schmutz; Sameh Mosaed
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.